Iktos

Engineering Software · France · 51-200 Employees

View Company Info for Free

Overview

Headquarters

65 Rue De Prony, Paris, Ile-de-France, 7...

Phone Number

+33 973584548

Revenue

$19.9 Million

Industry

Engineering Software Software

About Iktos

Iktos specializes in generative AI and robotics to enhance small-molecule drug discovery, significantly reducing timelines to under 24 months. Their flagship products include Makya, a generative AI platform for drug design, and Spaya, an AI-driven retrosynthesis platform. Targeting pharmaceutical, biotech, and academic institutions, Iktos aims to revolutionize drug development through automation and advanced data analysis. With a strong focus on collaboration, Iktos has established over 60 partnerships to push the boundaries of AI in drug discovery.Explore more
Iktos's Social MediaSIC Code 73,737NAICS Code 51,513Show more

Iktos Org Chart

PhoneEmail
PL
France flag for contact location.

Vice President & Head of Operations, Sales & ...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
Illustration of an envelope

Iktos Tech Stack

A closer look at the technologies used by Iktos

Top Engineering Software Companies

Frequently Asked Questions Regarding Iktos

What is Iktos's official website?
Iktos's official website is www.iktos.ai
What is Iktos's Revenue?
Iktos's revenue is $19.9 Million
What is Iktos's SIC code?
Iktos's SIC: 73,737
What is Iktos's NAICS code?
Iktos's NAICS: 51,513
How many employees does Iktos have?
Iktos has 51-200 employees
What industry does Iktos belong to?
Iktos is in the industry of: Engineering Software, Software
What companies has Iktos acquired?
Iktos has acquired the companies: Iktos, Synsight
What technology does Iktos use?
Some of the popular technologies that Iktos uses are: prismic, YouTube, Python, Google Tag Manager
How do I contact Iktos?
Iktos contact info: Phone number: +33 973584548 Website: www.iktos.ai
What does Iktos do?

Iktos specializes in generative AI and robotics to enhance small-molecule drug discovery, significantly reducing timelines to under 24 months. Their flagship products include Makya, a generative AI platform for drug design, and Spaya, an AI-driven retrosynthesis platform. Targeting pharmaceutical, biotech, and academic institutions, Iktos aims to r... evolutionize drug development through automation and advanced data analysis. With a strong focus on collaboration, Iktos has established over 60 partnerships to push the boundaries of AI in drug discovery.Read More

What are Iktos social media links?
Iktos Linkedin page Iktos Twitter page
Who invested in Iktos?
Iktos has 3 investors including The European Innovation Council, Omnes Capital and Merck Ventures.
Is Iktos a public company?
Iktos is private company therefore does not currently have an official ticker symbol
See more information about Iktos

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.